Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
17 September 2024 - EA65
Pharmacokinetics/Pharmacodynamics (PK/PD) of a Novel Nystatin-like Drug, BSG005, in Invasive Pulmonary Aspergillosis (IPA) and Invasive Candidiasis (IC)
Alexander J. Lepak, Justin Massey, David R. Andes
29 April 2024 - P2885
How can a Candida real-time PCR complement culture-based diagnostics of invasive candidiasis?
Elizabeth Nagy Roshdy Iskandar, Nicola Ferraro, Luca Dossena, Stefania Paolucci, Fausto Baldanti,
29 April 2024 - P2977
Treatment outcomes with rezafungin and caspofungin in adults with invasive candidiasis and/or candidaemia who had received no prior antifungal therapy: ReSTORE trial subgroup analysis
George Thompson, Alex Soriano, Matteo Bassetti, Oliver A. Cornely, , Patrick M. Honore, Methee Chayakulkeeree, Taylor Sandison, Nick Manamley, Peter Pappas
29 April 2024 - P2892
Diagnostic performance of different Candida antigens and anti-Candida antibody assays for the diagnosis of invasive candidiasis in ICU patients: an analysis of the CandiSep randomized clinical trial
Lea Standl, Timo Huber, Frank Bloos, Daniel Thomas-Rüddel, Renate Meyer, Jürgen Held
28 April 2024 - P2454
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasis
Omar Elkayal, Joost Wauters, Beatrijs Mertens, Ruth Van Daele, Katrien Lagrou, Erwin Dreesen, Isabel Spriet,
28 April 2024 - O0581
The novel second-generation IV/oral triterpenoid SCY-247 is efficacious in an experimental murine model of invasive candidiasis caused by Candida glabrata
Nathan Wiederhold, Laura Najvar, Rosie Jaramillo, Marcos Olivo, Hoja Patterson, Thomas F. Patterson
18 April 2023 - E1316
1,3-β-d-glucan as a treatment response biomarker in invasive candidiasis
Clare Logan, Phoebe Allebone-Salt, Andrea Mazzella, Will Hurt, Ka Fai Kong, Dagan Lonsdale, Carolyn Hemsley, Ali Abdolrasouli, Duncan Wyncoll, Silke Schelenz, Lewis White, Jessica Price, Tom Harrison, Tihana Bicanic
18 April 2023 - O1136
All-cause and attributable mortality in invasive candidiasis and/or Candidaemia with rezafungin and caspofungin treatment: outcomes from the ReSTORE trial
George Thompson, Oliver A Cornely, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
16 April 2023 - P1939
High prevalence of invasive candidiasis in neonates in Southeast Asia and the Pacific
Nina Dwi Putri, Riyadi Adrizain, Leny Kartina, Gayana Gunaratna, George Aho, Benjamin Dickson, Phoebe Williams
16 April 2023 - P1962
Comparison of three beta-glucan tests for the diagnosis of invasive candidiasis in intensive care units
Antonios Kritikos, Giorgia Caruana, Julien Poissy, Alexandre Mamin, Daniel Bachmann, Jean-Luc Pagani, Alix Coste, Frédéric Lamoth
16 April 2023 - P2088
In vivo efficacy of the novel azole compounds (ATTAF-1 and ATTAF-2) against invasive candidiasis in a murine model
Mehrnaz Mohammad Davoudi, Sepideh Nazeri, Kiana Abbasi, Hamed Fakhim, Afsane Vaezi, Hamid Morovati, Fatemeh Ahangarkani, Hamid Badali
16 April 2023 - P2061
Safety outcomes with rezafungin and caspofungin in the treatment of candidaemia and/or invasive candidiasis: phase 3 data from the ReSTORE trial
Alex Soriano, George R Thompson Rd, Oliver A Cornely, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
16 April 2023 - E0593
Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with Candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data
Oliver A Cornely, George R Thompson Rd, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
16 April 2023 - P2063
Treatment outcomes in candidaemia and/or invasive candidiasis among patients receiving rezafungin or caspofungin while the fungal culture was still positive
Oliver A. Cornely, George R Thompson Rd, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
16 April 2023 - P2048
Rezafungin and caspofungin treatment response in candidaemia/invasive candidiasis by baseline Candida species: analysis of pooled Phase 2 and Phase 3 results
George Thompson, Oliver A Cornely, Alex Soriano, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F Das, Taylor Sandison, Peter G Pappas
16 April 2023 - P2055
A novel protocol design to study the efficacy and safety of oral ibrexafungerp as step-down therapy following intravenous (IV) echinocandin for the treatment of invasive candidiasis (MARIO): developing a paradigm shift to IV and oral anti-cell wall therap
Luis Ostrosky-Zeichner, Oliver A Cornely, Jose Vazquez, Bart-Jan Kullberg, Thomas Walsh, Andrej Spec, Peter G Pappas, Nkechi E Azie, David A Angulo
26 April 2022 - O1004
Presence of C. parapsilosis fluconazole-resistant endemic clonally-related genotypes causing invasive candidiasis at a hospital in Palma de Mallorca, Spain
Eva Alcoceba, Paula Lara-Esbri, Antonio Oliver, Adriá Ferre-Beltrán, Ana Gómez-Nuñez, Patricia Muñoz, Pilar Escribano, Jesús Guinea
26 April 2022 - O0890
Successful containment of a cluster of invasive candidiasis caused by fluconazole-non-susceptible Candida parapsilosis in a neonatal intensive care unit
Hiroaki Baba, Hajime Kanamori, Takami Sato, Makoto Katsumi, Takae Chida, Shinobu Ikeda, Koichi Tokuda
25 April 2022 - O0571
Predictive model combining serial (1,3)-ß-d-glucan assay, risk factors and clinical signs for the diagnosis of invasive candidiasis in ICU patients: a prospective study
Flaminia Olearo, Beya Abdennadher, Dominic Wichmann, Stefan Kluge, Amra Hot, Martin Aepfelbacher, Holger Rohde, Martin Christner
25 April 2022 - B0034
Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomised, double-blinded, multi-centre phase II and phase III trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis
Alex Soriano, George R. Thompson, Oliver A Cornely, Bart-Jan Kullberg, Marin Kollef, Jose Vazquez, Patrick M. Honore, Matteo Bassetti, John Pullman, Cecilia Dignani, Anita F. Das, Taylor Sandison, Peter G. Pappas
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.